Curran Murphy

1.4k total citations
12 papers, 1.2k citations indexed

About

Curran Murphy is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Curran Murphy has authored 12 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Curran Murphy's work include Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Developmental Biology and Gene Regulation (2 papers). Curran Murphy is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Cancer Treatment and Pharmacology (4 papers) and Developmental Biology and Gene Regulation (2 papers). Curran Murphy collaborates with scholars based in United States and Australia. Curran Murphy's co-authors include Galina K. Sukhova, Peter Libby, Jorge Plutzky, Nikolaus Marx, Uwe Schönbeck, François Mach, Jean‐Yves Bonnefoy, Rosalind P. Fabunmi, Peter Libby and Elizabeth G. Atkinson and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and Blood.

In The Last Decade

Curran Murphy

12 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Curran Murphy United States	8	594	344	241	171	154	12	1.2k
Yevgenia Tesmenitsky United States	16	691 1.2×	619 1.8×	480 2.0×	212 1.2×	167 1.1×	22	1.4k
Juanjuan Ou China	22	627 1.1×	289 0.8×	284 1.2×	132 0.8×	169 1.1×	39	1.3k
Laura A. Maile United States	28	874 1.5×	317 0.9×	307 1.3×	132 0.8×	65 0.4×	48	1.5k
Scott A. Coats United States	10	428 0.7×	266 0.8×	206 0.9×	108 0.6×	80 0.5×	11	956
Yajun Feng United States	10	537 0.9×	189 0.5×	131 0.5×	130 0.8×	205 1.3×	13	1.1k
Yves Rival France	12	521 0.9×	249 0.7×	124 0.5×	80 0.5×	73 0.5×	15	1.1k
Laura S. Shankman United States	14	943 1.6×	702 2.0×	305 1.3×	208 1.2×	162 1.1×	17	1.6k
Stéphanie Gayral France	19	693 1.2×	223 0.6×	153 0.6×	154 0.9×	106 0.7×	27	1.3k
Amaya García de Vinuesa Netherlands	20	975 1.6×	181 0.5×	264 1.1×	123 0.7×	59 0.4×	24	1.6k
Ela Karshovska Germany	13	478 0.8×	298 0.9×	252 1.0×	114 0.7×	76 0.5×	17	871

Countries citing papers authored by Curran Murphy

Since Specialization

Citations

This map shows the geographic impact of Curran Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curran Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curran Murphy more than expected).

Fields of papers citing papers by Curran Murphy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curran Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curran Murphy. The network helps show where Curran Murphy may publish in the future.

Co-authorship network of co-authors of Curran Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Curran Murphy. A scholar is included among the top collaborators of Curran Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curran Murphy. Curran Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Tolcher, Anthony W., Pamela N. Münster, Lee S. Rosen, et al.. (2019). An open label, multicenter, phase 1b/2 study of rebastinib (DCC-2036) in combination with carboplatin to assess safety, tolerability, and pharmacokinetics in patients with advanced or metastatic solid tumors.. Journal of Clinical Oncology. 37(15_suppl). TPS2666–TPS2666. 2 indexed citations

2.

Wang, Andrew Z., Autumn J. McRee, A. William Blackstock, et al.. (2017). Phase Ib/II study of neoadjuvant chemoradiotherapy with CRLX101 and capecitabine for locally advanced rectal cancer.. Journal of Clinical Oncology. 35(15_suppl). e15144–e15144. 4 indexed citations

3.

Markman, Ben, Paul L. de Souza, Elizabeth Claire Dees, et al.. (2016). A phase 1 study of CRLX301, a novel nanoparticle-drug conjugate (NDC) containing docetaxel (DOC), in patients with refractory solid tumors.. Journal of Clinical Oncology. 34(15_suppl). 2526–2526. 18 indexed citations

4.

Zamboni, William C., Ben Markman, Paul de Souza, et al.. (2016). Abstract 2047: Pharmacokinetics (PK) of CRLX301, a novel nanoparticle-drug conjugate (NDC) containing the payload docetaxel, in patients with refractory solid tumors. Cancer Research. 76(14_Supplement). 2047–2047. 3 indexed citations

5.

Wang, Andrew Z., Hanna K. Sanoff, Autumn J. McRee, et al.. (2015). Phase IB/II study of neoadjuvant chemoradiotherapy with CRLX101 and capecitabine for locally advanced rectal cancer.. Journal of Clinical Oncology. 33(15_suppl). TPS3629–TPS3629. 1 indexed citations

6.

Dorsch, Marion, Gang Zheng, David Yowe, et al.. (2002). Ectopic expression of Delta4 impairs hematopoietic development and leads to lymphoproliferative disease. Blood. 100(6). 2046–2055. 53 indexed citations

7.

Dorsch, Marion, Gang Zheng, David Yowe, et al.. (2002). Ectopic expression of Delta4 impairs hematopoietic development and leads to lymphoproliferative disease. Blood. 100(6). 2046–2055. 45 indexed citations

8.

Kingsbury, Gillian A., Yuhua Nong, Curran Murphy, et al.. (2001). Cloning, Expression, and Function of BLAME, a Novel Member of the CD2 Family. The Journal of Immunology. 166(9). 5675–5680. 56 indexed citations

9.

Mach, François, Uwe Schönbeck, Rosalind P. Fabunmi, et al.. (1999). T Lymphocytes Induce Endothelial Cell Matrix Metalloproteinase Expression by a CD40L-Dependent Mechanism. American Journal Of Pathology. 154(1). 229–238. 150 indexed citations

10.

Marx, Nikolaus, Galina K. Sukhova, Curran Murphy, Peter Libby, & Jorge Plutzky. (1998). Macrophages in Human Atheroma Contain PPARγ. American Journal Of Pathology. 153(1). 17–23. 477 indexed citations

11.

Neve, Rachael L., et al.. (1998). The Neuronal Growth-Associated Protein GAP-43 Interacts with Rabaptin-5 and Participates in Endocytosis. Journal of Neuroscience. 18(19). 7757–7767. 89 indexed citations

12.

Schönbeck, Uwe, François Mach, Galina K. Sukhova, et al.. (1997). Regulation of Matrix Metalloproteinase Expression in Human Vascular Smooth Muscle Cells by T Lymphocytes. Circulation Research. 81(3). 448–454. 265 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact